Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2016	Dec. 31, 2015
CURRENT ASSETS:
Cash and Cash Equivalents, at Carrying Value	$ 14,764	$ 22,494
Accounts receivable, net of allowance for doubtful accounts of $3,139 and $4,136 at 2016 and 2015, respectively	114,329	145,689
Inventories, net	33,720	40,906
Prepaid Expense, Current	10,711	12,053
Income Taxes Receivable, Current	6,426	7,209
Other Assets, Current	6,511	10,196
TOTAL CURRENT ASSETS	186,461	238,547
Property, Plant and Equipment, Net	129,882	143,211
INTANGIBLES, net	9,936	10,041
GOODWILL	179,044	178,159
Deferred Tax Assets, Net, Noncurrent	20,605	11,693
Other Assets, Noncurrent	47,124	43,607
TOTAL ASSETS	573,052	625,258
CURRENT LIABILITIES:
Accounts payable	33,720	33,474
Accrued payroll and related costs	19,411	36,475
Taxes other than payroll and income	5,816	9,495
Unearned revenues	15,690	14,101
Income taxes payable	15,718	1,733
Other accrued expenses	13,668	25,480
TOTAL CURRENT LIABILITIES	104,023	120,758
LONG-TERM DEBT AND CAPITAL LEASE OBLIGATIONS	216,488	430,987
DEFERRED COMPENSATION	46,251	43,478
Deferred Tax Liabilities, Noncurrent	6,277	4,881
Other Liabilities, Noncurrent	44,716	48,853
COMMITMENTS AND CONTINGENCIES
EQUITY:
Preference shares, EUR 0.02 par value; 6,000,000 shares authorized, none issued or outstanding	0	0
Common shares, EUR 0.02 par value; 200,000,000 shares authorized, 44,796,252 issued and 44,151,261 outstanding at 2016 and 44,350,002 issued and 42,375,905 outstanding at 2015	1,148	1,142
Additional paid-in capital	52,850	0
Retained Earnings (Accumulated Deficit)	187,957	219,207
Accumulated Other Comprehensive Income (Loss), Net of Tax	(9,828)	(10,538)
Treasury shares (at cost), 644,991 at 2016 and 1,974,097 at 2015	(80,773)	(238,875)
Total Core Laboratories N.V. shareholders' equity	151,354	(29,064)
Stockholders' Equity Attributable to Noncontrolling Interest	3,943	5,365
TOTAL EQUITY	155,297	(23,699)
TOTAL LIABILITIES AND EQUITY	$ 573,052	$ 625,258